Injections, Subcutaneous - Research News and Information

Saturday, January 10, 2009

Fine ambient particles from various sites in europe exerted a greater IgE adjuvant effect than coarse ambient particles in a mouse model.

30 Dec 2008 In the European Union (EU)-funded project Respiratory Allergy and Inflammation due to Ambient Particles (RAIAP), coarse and fine ambient particulate matter (PM) was collected at traffic dominated locations in Oslo, Rome, Lodz, and Amsterdam, in the ... Read more...

Errors with concentrated epinephrine in otolaryngology.

30 Oct 2008 OBJECTIVES: Obtain data on errors and adverse events with concentrated epinephrine in otolaryngology. PROJECT DESIGN: Anonymous survey. METHODS: Confidential, voluntary, and online survey of Academy members. RESULTS: One hundred twenty-six surveys ... Read more...

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

19 Oct 2008 BACKGROUND: Injection of long-acting insulin at bedtime is a common therapeutic approach for patients with type 2 diabetes that is poorly controlled with oral regimens. Neutral protamine lispro (NPL) insulin has demonstrated better glycemic control ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Injections, Subcutaneous'

These are the very latest articles for this heading:

• Fine ambient particles from various sites in europe exerted a greater IgE adjuvant effect than coarse ambient particles in a mouse model. 30 Dec 2008
• Errors with concentrated epinephrine in otolaryngology. 30 Oct 2008
• Summaries for patients. Comparison of two types of insulin added to diabetes pills in poorly controlled type 2 diabetes. 19 Oct 2008
• Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial. 19 Oct 2008
• Certolizumab (Cimzia) for Crohn's disease. 18 Oct 2008
• Prolonged 5-HT1A/5-HT2A receptor cross-talk is absent prior to adulthood in rats. 6 Oct 2008
• Regional differential effects of chronic nicotine on brain alpha 4-containing and alpha 6-containing receptors. 6 Oct 2008
• GAD treatment and insulin secretion in recent-onset type 1 diabetes. 6 Oct 2008
• Microneedle-based drug delivery: studies on delivery parameters and biocompatibility. 29 Sep 2008
• Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer. 29 Sep 2008
• The biocompatibility of mesoporous silicates. 29 Sep 2008
• Treatment with tacrolimus enhances alveolar bone formation and decreases osteoclast number in the maxillae: a histomorphometric and ultrastructural study in rats. 29 Sep 2008
• Validation of the SoloSTAR insulin pen. 29 Sep 2008
• Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels. 29 Sep 2008
• Age-related changes in tissue and plasma zinc levels: modulation by exogenously administered melatonin. 29 Sep 2008
• Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat. 29 Sep 2008
• Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial. 29 Sep 2008
• Hydrodissection as key to a natural-appearing otoplasty. 29 Sep 2008
• Diamyd, an alum-formulated recombinant human GAD65 for the prevention of autoimmune diabetes. 29 Sep 2008
• The future is (almost) now. What's coming next for managing your diabetes. 29 Sep 2008

See a longer list of these articles.

Technical information about 'Injections, Subcutaneous'

Definition: Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.

Descriptor UI: D007279

Alternative terms: Injections, Subcutaneous; Subcutaneous Injections; Injection, Subcutaneous; Subcutaneous Injection;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics;

Tree Number: E02.319.267.530.620;

Technical Notes: NIM; do not use /util except by MeSH definition; DF: INJECT SUBCUTANEOUS